Long-term outcome of thyroid function after amiodarone-induced thyrotoxicosis, as compared to subacute thyroiditis
Abstract
Background Two main forms of amiodarone- induced thyrotoxicosis (AIT) exist: type 1 AIT is a condition of true hyperthyroidism developing in patients with pre-existing thyroid disorders, and usually requires thyroid ablative treatment. On the other hand, type 2 AIT is a form of destructive thyroiditis occurring in normal thyroids, the management of which usually consists in glucocorticoid treatment.Aim To assess the long-term outcome of thyroid function in a prospective study of type 2 AIT patients, as compared to patients with De Quervain's subacute thyroiditis (SAT).Patients and methods Sixty consecutive patients with type 2 AIT were evaluated during oral glucocorticoid treatment (oral prednisone 30 mg/day, gradually tapered and withdrawn over a 3-month period) and followed for 38+/-4 months (range 6-72) thereafter. Sixty consecutive patients with SAT, referred to our Institutes during the same period and treated with the same therapeutic schedule, served as controls.Results Type 2 AIT patients were older (p<0.0001) and showed a larger male preponderance (M:F 3.6:1 vs 0.5:1, p<0.0001) than SAT patients. Mean serum free T4 (FT4) and free T3 (FT3) concentrations at diagnosis were increased in both conditions, but higher in type 2 AIT than in SAT (FT4 47.6+/-18.8 and 29.6+/-8.3 pmol/l, respectively, p<0.0001; FT3 15.4+/-7.0 and 11.2+/-3.0 pmol/l, respectively, p<0.001). Correction of thyrotoxicosis was obtained in all patients in both groups, but restoration of euthyroidism occurred earlier in SAT than in type 2 AIT (p=0.006). Ten type 2 AIT patients (17%) and 3 SAT patients (5%, p<0.03) became permanently hypothyroid after glucocorticoid withdrawal and required levothyroxine replacement.Conclusions A relevant proportion of type 2 AIT patients develop permanent hypothyroidism after correction of thyrotoxicosis. Thus, periodic surveillance of thyroid status is required after type 2 AIT.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Patients recovering from apparent type 2 AIT should be monitored for permanent hypothyroidism, which appears to occur more often with AIT than with subacute thyroiditis.
“Patients recovering from apparent type 2 AIT should be monitored for permanent hypothyroidism, which appears to occur more often with AIT than with subacute thyroiditis (608).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [608]
Cites
Pearce, E. N., Farwell, A. P., & Braverman, L. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021194 · Cited by 878 · see citing works
The Effects of Amiodarone on the Thyroid
Martino, E., Bartalena, L., Bogazzi, F., & Braverman, L. E. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.2.0427 · Cited by 559 · see citing works
Self-citationFatourechi, V., Aniszewski, J. P., Fatourechi, G. Z. E., Atkinson, E. J., & Jacobsen, S. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021799 · Cited by 404 · see citing works
Environmental Iodine Intake and Thyroid Dysfunction During Chronic Amiodarone Therapy
Martino, E., SAFRAN, M., AGHINI-LOMBARDI, F., RAJATANAVIN, R., LENZIARDI, M., FAY, M., PACCHIAROTTI, A., ARONIN, N., MACCHIA, E., HAFFAJEE, C., et al. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-1-28 · Cited by 370 · see citing works
Self-citationIncidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism
Trip, M. D., Wiersinga, W. M., & Plomp, T. A. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90187-3 · Cited by 269 · see citing works
Bartalena, L., Brogioni, S., Grasso, L., Bogazzi, F., Burelli, A., & Martino, E. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.8.8768854 · Cited by 234 · see citing works
Self-citationBartalena, L., Bogazzi, F., Braverman, L. E., & Martino, E. (2001) · Journal of Endocrinological Investigation · doi:10.1007/bf03343825 · Cited by 199 · see citing works
Self-citationBogazzi, F., Bartalena, L., Brogioni, S., Mazzeo, S., Vitti, P., Burelli, A., Bartolozzi, C., & Martino, E. (1997) · Thyroid · doi:10.1089/thy.1997.7.541 · Cited by 190 · see citing works
Self-citationAmiodarone-Associated Thyroid Dysfunction
Thorne, S., Barnes, I. M., Cullinan, P., & Somerville, J. (1999) · Circulation · doi:10.1161/01.cir.100.2.149 · Cited by 149 · see citing works
Martino, E., Aghini-Lombardi, F., Mariotti, S., Lenziardi, M., Baschieri, L., Braverman, L. E., & Pinchera, A. (1986) · Journal of Endocrinological Investigation · doi:10.1007/bf03348098 · Cited by 149 · see citing works
Self-citationEaton, S. E. M., Euinton, H. A., Newman, C. M., Weetman, A. P., & Bennet, W. M. (2002) · Clinical Endocrinology · doi:10.1046/j.0300-0664.2001.01457.x · Cited by 139 · see citing works
Bogazzi, F., Bartalena, L., Brogioni, S., Burelli, A., Manetti, L., Tanda, M. L., Gasperi, M., & Martino, E. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1400452 · Cited by 135 · see citing works
Self-citationIodine‐induced thyrotoxicosis: analysis of eighty‐five consecutive cases
Léger, A., MASSIN, J. P., Laurent, M. F., Vincens, M., Auriol, M., Helal, O. B., Chomette, G., & Savoie, J. C. (1984) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1984.tb01212.x · Cited by 109 · see citing works
Successful Treatment of Amiodarone-Induced Thyrotoxicosis
Osman, F., Franklyn, J. A., Sheppard, M. C., & Gammage, M. D. (2002) · Circulation · doi:10.1161/circ.105.11.1275 · Cited by 96 · see citing works
Bartalena, L., Wiersinga, W. M., Tanda, M. L., Bogazzi, F., Piantanida, E., Lai, A., & Martino, E. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02119.x · Cited by 88 · see citing works
Self-citationBogazzi, F., Martino, E., Dell’Unto, E., Brogioni, S., Cosci, C., Aghini-Lombardi, F., Ceccarelli, C., Pinchera, A., Bartalena, L., & Braverman, L. E. (2003) · Journal of Endocrinological Investigation · doi:10.1007/bf03347021 · Cited by 71 · see citing works
Self-citationBogazzi, F., Miccoli, P., Berti, P., Cosci, C., Brogioni, S., Aghini-Lombardi, F., Materazzi, G., Bartalena, L., Pinchera, A., Braverman, L. E., et al. (2002) · Surgery · doi:10.1067/msy.2002.128561 · Cited by 63 · see citing works
Self-citationLio, S., Pontecorvi, A., Caruso, M., Monaco, F., & D’Armiento, M. (1984) · European Journal of Endocrinology · doi:10.1530/acta.0.1060067 · Cited by 59 · see citing works
Amiodarone‐induced thyrotoxicosis: a difficult diagnostic and therapeutic challenge*
Bartalena, L., Bogazzi, F., & Martino, E. (2002) · Clinical Endocrinology · doi:10.1046/j.0300-0664.2001.01458.x · Cited by 58 · see citing works
Self-citationWilliams, M. R., & Gerfo, P. L. (2002) · Thyroid · doi:10.1089/105072502760143926 · Cited by 56 · see citing works
Prednisone in amiodarone-induced thyrotoxicosis.
Wimpfheimer, C., Stäubli, M., Schädelin, J., & Studer, H. (1982) · BMJ · doi:10.1136/bmj.284.6332.1835-a · Cited by 54 · see citing works
Broussolle, C., Ducottet, X., Martin, C., Barbier, Y., Bornet, H., Noel, G., & Orgiazzi, J. (1989) · Journal of Endocrinological Investigation · doi:10.1007/bf03349916 · Cited by 53 · see citing works
Wiersinga, W. M. (1997) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-60709-7_10 · Cited by 53 · see citing works
Roti, E., Minelli, R., Gardini, E., Bianconi, L., Gavaruzzi, G., Ugolotti, G., Neri, T. M., & Braverman, L. E. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.5.1331165 · Cited by 52 · see citing works
Roti, E., Minelli, R., Gardini, E., et al. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-5-958 · Cited by 48 · see citing works
Pharmacotherapeutics of the Thyroid Gland
Weetman, A. P., & Grossman, A. (1997) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-60709-7 · Cited by 45 · see citing works
Iodine-Induced Hypothyroidism in Euthyroid Subjects with a Previous Episode of Subacute Thyroiditis*
Roti, E., Minelli, R., Gardini, E., Bianconi, L., & Braverman, L. E. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-6-1581 · Cited by 45 · see citing works
Amiodarone-Induced Thyroid Dysfunction
Iudica-Souza, C., & Burch, H. B. (1999) · The Endocrinologist · doi:10.1097/00019616-199905000-00008 · Cited by 35 · see citing works
Use of Oral Cholecystographic Agents in the Treatment of Amiodarone-Induced Hyperthyroidism
CHOPRA, I. J., & Baber, K. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.10.7976 · Cited by 30 · see citing works
Thyroid ultrasound as a predicator of thyroid disease
Vitti, P., & Rago, T. (2003) · Journal of Endocrinological Investigation · doi:10.1007/bf03347031 · Cited by 28 · see citing works
Bonnyns, M., Sterling, I., Renard, M., Bernard, R., Demaret, B., & Bourdoux, P. (1989) · PubMed · Cited by 17 · see citing works
Metabolic and ultrastructural aspects of experimental diabetic glomerulopathy
Martino, G., Botte, L., Gualà, L., et al. (1986) · Journal of Endocrinological Investigation · doi:10.1007/bf03348073 · Cited by 6 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0229 · Cited by 2,938 · see citing works
“Patients recovering from apparent type 2 AIT should be monitored for permanent hypothyroidism, which appears to occur more often with AIT than with subacute thyroiditis (608).”
BackgroundTreatment of Amiodarone-Induced Thyrotoxicosis Type 2: A Randomized Clinical Trial
Eskes, S. A., Endert, E., Fliers, E., Geskus, R. B., Dullaart, R. P. F., Links, T. P., & Wiersinga, W. M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2390 · Cited by 78 · see citing works
Stan, M. N., Sathananthan, M., Warnes, C. A., Brennan, M. D., Thapa, P., & Bahn, R. S. (2014) · Endocrine Practice · doi:10.4158/ep13059.or · Cited by 18 · see citing works
- Authors
- Bogazzi, F., Dell’Unto, E., Tanda, M. L., Tomisti, L., Cosci, C., Aghini-Lombardi, F., Sardella, C., Pinchera, A., Bartalena, L., & Martino, E.
- Affiliations
- University of Pisa (IT)
- University of Insubria (IT)
- Corresponding author
- Bogazzi, F.
- Venue
- Journal of Endocrinological Investigation
- Published
- 2006-09
- Volume
- 29
- Issue
- 8
- Pages
- 694-699
- ISSN
- 0391-4097 (ISSN-L)
- 1720-8386
- OpenAlex
- W2083836553
- Cited by
- 49
- References
- 32
- Citations by year
- 2026: 1 · 2022: 4 · 2021: 3 · 2020: 3 · 2019: 1 · 2018: 4 · 2017: 1 · 2016: 1 · 2015: 3 · 2014: 1 · 2013: 1 · 2012: 5
- FWCI
- 3.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Endocrinological Investigation (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- IrInSubria (University of Insubria) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Pathology and Forensic Medicine › Ophthalmology and Eye Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- amiodarone-induced thyrotoxicosis, subacute thyroiditis, De Quervain's thyroiditis, glucocorticoid therapy, prednisone, permanent hypothyroidism, levothyroxine replacement, thyroid function, long-term outcomes, thyroid surveillance, hyperthyroidism
- MeSH terms
- Adult, Aged, Aged, 80 and over, Amiodarone, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prospective Studies, Thyroid Function Tests, Thyroid Gland, Thyroiditis, Subacute, Thyrotoxicosis, Time Factors, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review